Research We Fund
Your generous support enables us to fund millions of dollars in research every year, in locations across the globe. We fund projects across the research pipeline, from basic research through clinical trials, and our support has led to several potential treatments currently in clinical trials.
Safenowitz Postdoctoral Fellowship Program
The Milton Safenowitz Postdoctoral Fellowship for ALS Research awards are designed to encourage and facilitate young scientists to enter the field of ALS Research. Our organization has funded 5 fellows who work with a senior mentor and receive extensive exposure to the ALS research community. More than 90% of the fellows remain in ALS research and contribute significantly to advances made in the field.
Nishal Shah PhD, Stanford University, California – Research on Intracortical Brain Computer Interface Technology
Lauren Gittings PhD, Barrow Institute, Phoenix, Arizona – Understanding the Pathology of C9orf72 Gene and ALS/FTD.
Sarah Ackerman PhD, University of Oregon, Eugene, OR - Contributions of astrocyte function and dysfunction to ALS
Individual Research Projects
Joe Beckman PhD, Oregon State University, Corvallis, OR - Preclinical investigation of CuATSM in mice and dogs as a precursor for ALS therapy development
Nick Olney MD, Providence ALS Center, Portland, OR – ALS Natural History Pilot Project
Yaowaree Leavell MD, Department of Neurology, Portland Veterans Affairs Hospital, Oregon - Understanding patient and care-partner experiences of primary and specialist palliative care: a qualitative needs assessment at a Veteran’s Affairs ALS Center
Jeffrey Rothstein MD, Johns Hopkins University, Baltimore Maryland - ASO mediated knockdown of CHMP7 as a novel therapeutic strategy for ALS/FTD
Daniel Fowler MD, Rapa Therapeutics, Rockville, Maryland - RAPA-501 Hybrid TREG/TH2 Cell therapy in ALS